These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1347583)

  • 21. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T; Ferro G; Frontini V; Percolla S
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desferrioxamine infusion can modify EEG tracing in haemodialysed patients.
    Brancaccio D; Avanzini G; Padovese P; Gallieni M; Franceschetti S; Panzica F; Anelli A; Colantonio G; Martinelli D; Bugiani O
    Nephrol Dial Transplant; 1991; 6(4):264-8. PubMed ID: 1881580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel delivery system for continuous desferrioxamine infusion in iron-overloaded patients.
    Fielding A; Wonke B
    Lancet; 1992 Sep; 340(8822):790-1. PubMed ID: 1356198
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS).
    Reising CA; Chendrasekhar A; Wall PL; Paradise NF; Timberlake GA; Moorman DW
    J Surg Res; 1999 Mar; 82(1):56-60. PubMed ID: 10068526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
    Fisher EA; McLachlan DR; Kruck TP; Mustard RA
    Pharmacology; 1990; 41(5):263-71. PubMed ID: 2092330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary syndrome and intravenous high-dose desferrioxamine.
    Castriota Scanderbeg A; Izzi GC; Butturini A; Benaglia G
    Lancet; 1990 Dec; 336(8729):1511. PubMed ID: 1979119
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute bone marrow aplasia associated with intravenous administration of deferoxamine (desferrioxamine).
    Sofroniadou K; Drossou M; Foundoulaki L; Konstantopoulos K; Kyriakoy D; Zervas J
    Drug Saf; 1990; 5(2):152-4. PubMed ID: 2322425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal failure occurring during intravenous desferrioxamine therapy: recovery after haemodialysis.
    Cianciulli P; Sorrentino F; Forte L; Palombi M; Papa G; Meloni C; Taccone Gallucci M; Casciani CU
    Haematologica; 1992; 77(6):514-5. PubMed ID: 1289188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status.
    Smith TG; Balanos GM; Croft QP; Talbot NP; Dorrington KL; Ratcliffe PJ; Robbins PA
    J Physiol; 2008 Dec; 586(24):5999-6005. PubMed ID: 18955380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of the use of desferrioxamine B in iron overload.
    Propper RD; Shurin SB; Nathan DG
    N Engl J Med; 1976 Jun; 294(26):1421-3. PubMed ID: 1272274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult respiratory distress syndrome following thrombolytic therapy for pulmonary embolism.
    Martin TR; Sandblom RL; Johnson RJ
    Chest; 1983 Jan; 83(1):151-3. PubMed ID: 6848325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
    Olivieri NF; Koren G; Hermann C; Bentur Y; Chung D; Klein J; St Louis P; Freedman MH; McClelland RA; Templeton DM
    Lancet; 1990 Nov; 336(8726):1275-9. PubMed ID: 1978115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute respiratory distress syndrome].
    Andrejaitiene J
    Medicina (Kaunas); 2003; 39(11):1044-56. PubMed ID: 14646457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies in acute iron poisoning. II. Further observations on desferrioxamine in the treatment of acute experimental iron poisoning.
    Whitten CF; Chen YC; Gibson GW
    Pediatrics; 1966 Jul; 38(1):102-10. PubMed ID: 5937669
    [No Abstract]   [Full Text] [Related]  

  • 36. Iron poisoning--a preventable hazard of childhood.
    Reynolds LG; Klein M
    S Afr Med J; 1985 Apr; 67(17):680-3. PubMed ID: 3992389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of iron and desferrioxamine on the lung injury induced by intravenous bleomycin and hyperoxia.
    Hay JG; Haslam PL; Turner-Warwick M; Laurent GJ
    Free Radic Res Commun; 1987; 4(2):109-14. PubMed ID: 2468585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of acute iron poisoning. Contribution on the therapy of acute iron poisoning with the iron complex constituent desferrioxamine B].
    Scherzinger F
    Monatsschr Kinderheilkd (1902); 1966 Dec; 114(12):596-7. PubMed ID: 5998613
    [No Abstract]   [Full Text] [Related]  

  • 39. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury.
    Reddy BR; Wynne J; Kloner RA; Przyklenk K
    Cardiovasc Res; 1991 Sep; 25(9):711-8. PubMed ID: 1799904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful desensitization of a child with desferrioxamine hypersensitivity.
    Patriarca G; Schiavino D; Nucera E; Pellegrino S; Valle D; Della Corte AM; Pagliari G
    J Investig Allergol Clin Immunol; 1995; 5(5):294-5. PubMed ID: 8574439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.